{"version":"1.0","type":"link","title":"Efficacy of continuing pembrolizumab after progression on first-line treatment in stage IV non-small cell lung cancer: a prospective real-world study.","author_name":"Ruan K 외","author_url":"https://prs-insight.online/author/Ruan%20K","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/101798","thumbnail_width":1200,"thumbnail_height":630}